nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—Sulfapyridine—Vismodegib—skin cancer	0.361	1	CrCrCtD
Dapsone—PTGS2—skin cancer	0.231	1	CbGaD
Dapsone—CYP2C8—Vismodegib—skin cancer	0.0445	0.143	CbGbCtD
Dapsone—CYP2C19—Vismodegib—skin cancer	0.0373	0.12	CbGbCtD
Dapsone—CYP2E1—Dacarbazine—skin cancer	0.0361	0.116	CbGbCtD
Dapsone—CYP2C9—Vismodegib—skin cancer	0.031	0.0998	CbGbCtD
Dapsone—CYP3A4—Temozolomide—skin cancer	0.026	0.0837	CbGbCtD
Dapsone—CYP3A4—Imiquimod—skin cancer	0.026	0.0837	CbGbCtD
Dapsone—CYP3A4—Vismodegib—skin cancer	0.018	0.058	CbGbCtD
Dapsone—CYP3A7—Docetaxel—skin cancer	0.0167	0.0538	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0167	0.0538	CbGbCtD
Dapsone—CYP2C8—Fluorouracil—skin cancer	0.0158	0.0508	CbGbCtD
Dapsone—CYP3A4—Vemurafenib—skin cancer	0.0143	0.0459	CbGbCtD
Dapsone—CYP3A5—Docetaxel—skin cancer	0.0126	0.0404	CbGbCtD
Dapsone—CYP2C9—Fluorouracil—skin cancer	0.011	0.0354	CbGbCtD
Dapsone—Application site dryness—Imiquimod—skin cancer	0.0107	0.129	CcSEcCtD
Dapsone—Phototoxicity—Imiquimod—skin cancer	0.00643	0.0776	CcSEcCtD
Dapsone—Application site burn—Imiquimod—skin cancer	0.00588	0.071	CcSEcCtD
Dapsone—Application site erythema—Imiquimod—skin cancer	0.00523	0.0631	CcSEcCtD
Dapsone—Application site pruritus—Imiquimod—skin cancer	0.00505	0.0609	CcSEcCtD
Dapsone—CYP3A4—Docetaxel—skin cancer	0.00489	0.0157	CbGbCtD
Dapsone—Localized exfoliation—Bleomycin—skin cancer	0.00325	0.0392	CcSEcCtD
Dapsone—Application site burn—Fluorouracil—skin cancer	0.00325	0.0392	CcSEcCtD
Dapsone—Application site pain—Imiquimod—skin cancer	0.0028	0.0338	CcSEcCtD
Dapsone—Application site reaction—Imiquimod—skin cancer	0.00263	0.0317	CcSEcCtD
Dapsone—Application site pain—Fluorouracil—skin cancer	0.00155	0.0187	CcSEcCtD
Dapsone—Application site reaction—Fluorouracil—skin cancer	0.00145	0.0175	CcSEcCtD
Dapsone—Proteinuria—Imiquimod—skin cancer	0.0014	0.0169	CcSEcCtD
Dapsone—Protein urine present—Imiquimod—skin cancer	0.00138	0.0167	CcSEcCtD
Dapsone—Skin exfoliation—Imiquimod—skin cancer	0.00118	0.0142	CcSEcCtD
Dapsone—MPO—endothelium—skin cancer	0.000954	0.0682	CbGeAlD
Dapsone—PTGS2—leg—skin cancer	0.000935	0.0669	CbGeAlD
Dapsone—MPO—blood vessel—skin cancer	0.000879	0.0629	CbGeAlD
Dapsone—Skin exfoliation—Bleomycin—skin cancer	0.000835	0.0101	CcSEcCtD
Dapsone—PTGS2—hindlimb—skin cancer	0.000835	0.0597	CbGeAlD
Dapsone—Photosensitivity reaction—Vemurafenib—skin cancer	0.000827	0.00999	CcSEcCtD
Dapsone—Neuropathy peripheral—Vemurafenib—skin cancer	0.000792	0.00956	CcSEcCtD
Dapsone—Influenza—Imiquimod—skin cancer	0.000773	0.00933	CcSEcCtD
Dapsone—PTGS2—appendage—skin cancer	0.000716	0.0512	CbGeAlD
Dapsone—Photosensitivity reaction—Imiquimod—skin cancer	0.000705	0.00852	CcSEcCtD
Dapsone—Skin exfoliation—Temozolomide—skin cancer	0.000705	0.00851	CcSEcCtD
Dapsone—Gastrointestinal pain—Vismodegib—skin cancer	0.000682	0.00823	CcSEcCtD
Dapsone—Neuropathy peripheral—Imiquimod—skin cancer	0.000675	0.00815	CcSEcCtD
Dapsone—Abdominal pain—Vismodegib—skin cancer	0.000659	0.00796	CcSEcCtD
Dapsone—Sinusitis—Imiquimod—skin cancer	0.000646	0.0078	CcSEcCtD
Dapsone—Erythema—Vemurafenib—skin cancer	0.000631	0.00762	CcSEcCtD
Dapsone—Pharyngitis—Imiquimod—skin cancer	0.000614	0.00741	CcSEcCtD
Dapsone—PTGS2—skin epidermis—skin cancer	0.000596	0.0426	CbGeAlD
Dapsone—CYP2C18—mammalian vulva—skin cancer	0.000585	0.0419	CbGeAlD
Dapsone—Tinnitus—Imiquimod—skin cancer	0.000577	0.00696	CcSEcCtD
Dapsone—FMO3—mammalian vulva—skin cancer	0.000563	0.0403	CbGeAlD
Dapsone—Cough—Vemurafenib—skin cancer	0.000551	0.00665	CcSEcCtD
Dapsone—Erythema—Imiquimod—skin cancer	0.000538	0.0065	CcSEcCtD
Dapsone—Vomiting—Vismodegib—skin cancer	0.00053	0.0064	CcSEcCtD
Dapsone—Nausea—Vismodegib—skin cancer	0.000495	0.00598	CcSEcCtD
Dapsone—Muscular weakness—Temozolomide—skin cancer	0.000473	0.00571	CcSEcCtD
Dapsone—Cough—Imiquimod—skin cancer	0.00047	0.00567	CcSEcCtD
Dapsone—Skin exfoliation—Docetaxel—skin cancer	0.000469	0.00566	CcSEcCtD
Dapsone—PTGS1—endothelium—skin cancer	0.000452	0.0324	CbGeAlD
Dapsone—MPO—connective tissue—skin cancer	0.000451	0.0323	CbGeAlD
Dapsone—Nasopharyngitis—Fluorouracil—skin cancer	0.000442	0.00533	CcSEcCtD
Dapsone—Muscular weakness—Fluorouracil—skin cancer	0.000435	0.00526	CcSEcCtD
Dapsone—PTGS2—endothelium—skin cancer	0.000432	0.0309	CbGeAlD
Dapsone—Tachycardia—Imiquimod—skin cancer	0.000429	0.00518	CcSEcCtD
Dapsone—MPO—epithelium—skin cancer	0.000428	0.0306	CbGeAlD
Dapsone—Photosensitivity reaction—Temozolomide—skin cancer	0.000423	0.0051	CcSEcCtD
Dapsone—PTGS1—blood vessel—skin cancer	0.000417	0.0298	CbGeAlD
Dapsone—Body temperature increased—Vemurafenib—skin cancer	0.000407	0.00492	CcSEcCtD
Dapsone—MPO—skin of body—skin cancer	0.000407	0.0291	CbGeAlD
Dapsone—Pharyngitis—Dactinomycin—skin cancer	0.000407	0.00491	CcSEcCtD
Dapsone—Neuropathy peripheral—Temozolomide—skin cancer	0.000405	0.00489	CcSEcCtD
Dapsone—FMO3—head—skin cancer	0.000403	0.0288	CbGeAlD
Dapsone—PTGS2—blood vessel—skin cancer	0.000399	0.0285	CbGeAlD
Dapsone—Insomnia—Imiquimod—skin cancer	0.000397	0.0048	CcSEcCtD
Dapsone—Photosensitivity reaction—Fluorouracil—skin cancer	0.00039	0.0047	CcSEcCtD
Dapsone—Sinusitis—Temozolomide—skin cancer	0.000387	0.00468	CcSEcCtD
Dapsone—Erythema—Bleomycin—skin cancer	0.000383	0.00462	CcSEcCtD
Dapsone—Neuropathy peripheral—Fluorouracil—skin cancer	0.000373	0.0045	CcSEcCtD
Dapsone—Pharyngitis—Temozolomide—skin cancer	0.000368	0.00444	CcSEcCtD
Dapsone—Gastrointestinal pain—Imiquimod—skin cancer	0.000359	0.00434	CcSEcCtD
Dapsone—Sinusitis—Fluorouracil—skin cancer	0.000357	0.00431	CcSEcCtD
Dapsone—Erythema—Dactinomycin—skin cancer	0.000357	0.00431	CcSEcCtD
Dapsone—Abdominal pain—Imiquimod—skin cancer	0.000347	0.00419	CcSEcCtD
Dapsone—Body temperature increased—Imiquimod—skin cancer	0.000347	0.00419	CcSEcCtD
Dapsone—Tinnitus—Temozolomide—skin cancer	0.000346	0.00417	CcSEcCtD
Dapsone—Pharyngitis—Fluorouracil—skin cancer	0.000339	0.00409	CcSEcCtD
Dapsone—Cough—Bleomycin—skin cancer	0.000334	0.00403	CcSEcCtD
Dapsone—MPO—lymphoid tissue—skin cancer	0.00033	0.0236	CbGeAlD
Dapsone—Vomiting—Vemurafenib—skin cancer	0.000328	0.00396	CcSEcCtD
Dapsone—Headache—Vemurafenib—skin cancer	0.000323	0.0039	CcSEcCtD
Dapsone—Erythema—Temozolomide—skin cancer	0.000323	0.0039	CcSEcCtD
Dapsone—Nasopharyngitis—Docetaxel—skin cancer	0.000319	0.00385	CcSEcCtD
Dapsone—Nausea—Vemurafenib—skin cancer	0.000306	0.0037	CcSEcCtD
Dapsone—Vision blurred—Temozolomide—skin cancer	0.000304	0.00367	CcSEcCtD
Dapsone—PTGS1—nipple—skin cancer	0.000302	0.0216	CbGeAlD
Dapsone—Erythema—Fluorouracil—skin cancer	0.000297	0.00359	CcSEcCtD
Dapsone—Vertigo—Temozolomide—skin cancer	0.00029	0.0035	CcSEcCtD
Dapsone—FMO3—lymph node—skin cancer	0.000282	0.0202	CbGeAlD
Dapsone—Cough—Temozolomide—skin cancer	0.000282	0.0034	CcSEcCtD
Dapsone—Vision blurred—Fluorouracil—skin cancer	0.00028	0.00338	CcSEcCtD
Dapsone—Vomiting—Imiquimod—skin cancer	0.000279	0.00337	CcSEcCtD
Dapsone—Headache—Imiquimod—skin cancer	0.000275	0.00332	CcSEcCtD
Dapsone—Neuropathy peripheral—Docetaxel—skin cancer	0.000269	0.00325	CcSEcCtD
Dapsone—MPO—head—skin cancer	0.000266	0.019	CbGeAlD
Dapsone—Nausea—Imiquimod—skin cancer	0.000261	0.00315	CcSEcCtD
Dapsone—Body temperature increased—Bleomycin—skin cancer	0.000247	0.00298	CcSEcCtD
Dapsone—Pharyngitis—Docetaxel—skin cancer	0.000245	0.00295	CcSEcCtD
Dapsone—Insomnia—Temozolomide—skin cancer	0.000238	0.00288	CcSEcCtD
Dapsone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000238	0.00287	CcSEcCtD
Dapsone—Tachycardia—Fluorouracil—skin cancer	0.000237	0.00286	CcSEcCtD
Dapsone—Abdominal pain—Dactinomycin—skin cancer	0.00023	0.00278	CcSEcCtD
Dapsone—Body temperature increased—Dactinomycin—skin cancer	0.00023	0.00278	CcSEcCtD
Dapsone—Insomnia—Fluorouracil—skin cancer	0.000219	0.00265	CcSEcCtD
Dapsone—Gastrointestinal pain—Temozolomide—skin cancer	0.000215	0.0026	CcSEcCtD
Dapsone—Erythema—Docetaxel—skin cancer	0.000215	0.00259	CcSEcCtD
Dapsone—PTGS1—connective tissue—skin cancer	0.000214	0.0153	CbGeAlD
Dapsone—Abdominal pain—Temozolomide—skin cancer	0.000208	0.00251	CcSEcCtD
Dapsone—Body temperature increased—Temozolomide—skin cancer	0.000208	0.00251	CcSEcCtD
Dapsone—PTGS2—connective tissue—skin cancer	0.000204	0.0146	CbGeAlD
Dapsone—PTGS1—epithelium—skin cancer	0.000203	0.0145	CbGeAlD
Dapsone—Vomiting—Bleomycin—skin cancer	0.000199	0.0024	CcSEcCtD
Dapsone—PTGS2—epithelium—skin cancer	0.000194	0.0139	CbGeAlD
Dapsone—PTGS1—skin of body—skin cancer	0.000193	0.0138	CbGeAlD
Dapsone—Body temperature increased—Fluorouracil—skin cancer	0.000192	0.00232	CcSEcCtD
Dapsone—Cough—Docetaxel—skin cancer	0.000187	0.00226	CcSEcCtD
Dapsone—CYP2C8—female reproductive system—skin cancer	0.000186	0.0133	CbGeAlD
Dapsone—MPO—lymph node—skin cancer	0.000186	0.0133	CbGeAlD
Dapsone—Nausea—Bleomycin—skin cancer	0.000185	0.00224	CcSEcCtD
Dapsone—Vomiting—Dactinomycin—skin cancer	0.000185	0.00224	CcSEcCtD
Dapsone—PTGS2—skin of body—skin cancer	0.000185	0.0132	CbGeAlD
Dapsone—PTGS1—mammalian vulva—skin cancer	0.000176	0.0126	CbGeAlD
Dapsone—Nausea—Dactinomycin—skin cancer	0.000173	0.00209	CcSEcCtD
Dapsone—Tachycardia—Docetaxel—skin cancer	0.000171	0.00206	CcSEcCtD
Dapsone—Vomiting—Temozolomide—skin cancer	0.000167	0.00202	CcSEcCtD
Dapsone—CYP2C9—female reproductive system—skin cancer	0.000165	0.0118	CbGeAlD
Dapsone—Headache—Temozolomide—skin cancer	0.000165	0.00199	CcSEcCtD
Dapsone—CYP2E1—lymphoid tissue—skin cancer	0.000162	0.0116	CbGeAlD
Dapsone—Insomnia—Docetaxel—skin cancer	0.000158	0.00191	CcSEcCtD
Dapsone—CYP2E1—female reproductive system—skin cancer	0.000157	0.0112	CbGeAlD
Dapsone—Nausea—Temozolomide—skin cancer	0.000156	0.00189	CcSEcCtD
Dapsone—Vomiting—Fluorouracil—skin cancer	0.000154	0.00186	CcSEcCtD
Dapsone—Headache—Fluorouracil—skin cancer	0.000152	0.00184	CcSEcCtD
Dapsone—PTGS1—female reproductive system—skin cancer	0.000151	0.0108	CbGeAlD
Dapsone—PTGS2—lymphoid tissue—skin cancer	0.000149	0.0107	CbGeAlD
Dapsone—PTGS2—female reproductive system—skin cancer	0.000144	0.0103	CbGeAlD
Dapsone—Nausea—Fluorouracil—skin cancer	0.000144	0.00174	CcSEcCtD
Dapsone—Gastrointestinal pain—Docetaxel—skin cancer	0.000143	0.00173	CcSEcCtD
Dapsone—Body temperature increased—Docetaxel—skin cancer	0.000138	0.00167	CcSEcCtD
Dapsone—Abdominal pain—Docetaxel—skin cancer	0.000138	0.00167	CcSEcCtD
Dapsone—CYP2E1—head—skin cancer	0.000131	0.00936	CbGeAlD
Dapsone—PTGS1—head—skin cancer	0.000126	0.00902	CbGeAlD
Dapsone—CYP3A4—female reproductive system—skin cancer	0.000126	0.00901	CbGeAlD
Dapsone—PTGS2—head—skin cancer	0.00012	0.00862	CbGeAlD
Dapsone—Vomiting—Docetaxel—skin cancer	0.000111	0.00134	CcSEcCtD
Dapsone—Headache—Docetaxel—skin cancer	0.00011	0.00132	CcSEcCtD
Dapsone—Nausea—Docetaxel—skin cancer	0.000104	0.00126	CcSEcCtD
Dapsone—PTGS1—lymph node—skin cancer	8.82e-05	0.00631	CbGeAlD
Dapsone—PTGS2—lymph node—skin cancer	8.43e-05	0.00603	CbGeAlD
